Comment: Health care provider challenges for reaching Hispanic immigrants with HPV vaccination in rural Georgia

Somsri Wiwanitkit; Viroj Wiwanitkit
April 2012
Rural & Remote Health;Apr-Jun2012, Vol. 12 Issue 2, p1
Academic Journal
A letter to the editor is presented in response to the article "Health Care Provider Challenges for Reaching Hispanic Immigrants With HPV Vaccination in Rural Georgia" by J. S. Luque et al.


Related Articles

  • Recent Developments in Health Law. Ang, Ching Ping; Wolpin, Joseph; Baron, Elisha // Journal of Law, Medicine & Ethics;Spring2009, Vol. 37 Issue 1, p149 

    The article discusses the validity of requiring females aged 11-26 years seeking status as permanent resident to produce documentation that they have received the human papillomavirus (HPV) vaccine in the U.S. It is said that there is no legislative or regulatory check on whether the requirement...

  • COMPARING HPV VACCINES.  // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;10/22/2011, Vol. 343 Issue 7828, p809 

    No abstract available.

  • US committee recommends HPV vaccine for boys. Roehr, Bob // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;11/5/2011, Vol. 343 Issue 7830, p927 

    The article reports on a U.S. committee, which recommended mandatory quadrivalent vaccination to all boys in the U.S. against human papillomavirus (HPV) infection.

  • Planned Parenthood Receives Anonymous Donation for HPV Vaccine.  // La Prensa San Diego;2/26/2010, Vol. 34 Issue 8, p5 

    The article reports on the 300,000 dollars worth of gift given to the Planned Parenthood of San Diego & Riverside Counties in California to provide 19-26-year old women with the human papilloma virus (HPV) vaccine Gardasil.

  • An even larger problem than suggested. Serota, Fredric T. // Contemporary Pediatrics;Feb2007, Vol. 24 Issue 2, p110 

    A letter to the editor about papillomavirus vaccines is presented.

  • Accuracy in images. Schumacher, Albert // CMAJ: Canadian Medical Association Journal;12/2/2008, Vol. 179 Issue 12, p1301 

    A letter to the editor is presented in response to the article on human papillomavirus (HPV) vaccine in the September 9, 2008 issue.

  • Progress reported on antisense chemistries.  // AIDS Patient Care & STDs;Feb1997, Vol. 11 Issue 1, p37 

    Reports on antisense chemistries for HIV and STDs issued at the meeting in Paris highlighting promising agents from Hybridon. Vitro experiments using GEM 132; Antisense compound targeted against human papilloma virus.

  • Quadrivalent HPV Vaccine Safe and Effective in Men.  // Clinical Infectious Diseases;10/1/2010, Vol. 51 Issue 7, pii 

    The article offers information on the report which was presented at AIDS 2010 conference in Vienna, Austria regarding the safety and effectiveness of the quadrivalent human papilomavirus (HPV) vaccine Gardasil for men.

  • Appendix 1: Model protocol for the manufacturing and control of recombinant human papillomavirus virus-like particle vaccines.  // WHO Technical Report Series;2016, Issue 999, p216 

    An appendix is presented of model protocol for manufacturing and control of recombinant human papillomavirus virus-like particle vaccines from the World Health Organization.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics